Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
OGI logo OGI
Upturn stock ratingUpturn stock rating
OGI logo

OrganiGram Holdings Inc (OGI)

Upturn stock ratingUpturn stock rating
$1.29
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: OGI (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -62.9%
Avg. Invested days 22
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 165.34M USD
Price to earnings Ratio -
1Y Target Price 8.8
Price to earnings Ratio -
1Y Target Price 8.8
Volume (30-day avg) 922806
Beta 1.04
52 Weeks Range 1.24 - 2.91
Updated Date 02/21/2025
52 Weeks Range 1.24 - 2.91
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.34

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-02-11
When Before Market
Estimate -0.021
Actual -0.1444

Profitability

Profit Margin -31.69%
Operating Margin (TTM) -15.92%

Management Effectiveness

Return on Assets (TTM) -5.56%
Return on Equity (TTM) -54.53%

Valuation

Trailing PE -
Forward PE 28.99
Enterprise Value 135411953
Price to Sales(TTM) 1
Enterprise Value 135411953
Price to Sales(TTM) 1
Enterprise Value to Revenue 1.16
Enterprise Value to EBITDA 9.27
Shares Outstanding 126217000
Shares Floating 90352465
Shares Outstanding 126217000
Shares Floating 90352465
Percent Insiders 28.42
Percent Institutions 6.5

AI Summary

OrganiGram Holdings Inc. (OGI): A Comprehensive Overview

Company Profile:

Detailed History and Background:

OrganiGram Holdings Inc. (OGI) is a leading Canadian licensed producer of cannabis and cannabis-derived products. Founded in 2013, the company has grown rapidly to become a vertically integrated cannabis company with operations across cultivation, processing, and distribution. OGI holds a standard cultivation license, a processing license, and a sales license for cannabis under the Cannabis Act.

Core Business Areas:

  • Cultivation: OGI cultivates high-quality cannabis in its two indoor facilities in Moncton, New Brunswick, with a total annual production capacity of 113,000 kg.
  • Processing: The company processes cannabis into various consumer products, including dried flower, pre-rolls, oils, concentrates, and edibles.
  • Distribution: OGI distributes its products to recreational and medical cannabis markets across Canada through its own sales team and third-party distributors.

Leadership Team and Corporate Structure:

  • Beena Goldenberg (Chair and CEO)
  • Greg Engel (President)
  • Derek Correia (Chief Financial Officer)
  • Pat DiNardo (Chief Commercial Officer)
  • Nathalie Bourque (Chief Human Resources Officer)
  • Dr. Darren Carrigan (Chief Science Officer)

Top Products and Market Share:

Top Products:

  • Edison Cannabis: A premium dried flower brand known for its consistent quality and terpene profiles.
  • Big Bag o' Buds: A value-oriented dried flower brand offering high-quality cannabis at an affordable price.
  • La Confidential Pre-Rolls: A popular pre-roll option with a smooth and flavorful smoking experience.
  • Trailblazer Shatter: A high-potency cannabis concentrate for experienced users.
  • Afghan Kush Indica Softgels: A medical cannabis product for patients seeking pain relief and relaxation.

Market Share:

OGI holds a significant market share in the Canadian cannabis market, with a focus on the recreational market. The company ranks among the top 10 licensed producers in Canada by market share.

Total Addressable Market:

The global cannabis market is estimated to reach USD 103.4 billion by 2028, experiencing a CAGR of 20.3% during the forecast period. The Canadian cannabis market is expected to reach CAD 6.7 billion by 2026, with continued growth driven by increasing legalization and consumer demand.

Financial Performance:

Recent Financial Statements:

  • Revenue: In FY2023, OGI generated revenue of CAD 109.2 million, representing a 12% increase year-over-year.
  • Net Income: The company reported a net loss of CAD 7.2 million in FY2023, compared to a net loss of CAD 26.3 million in FY2022.
  • Profit Margin: OGI's gross profit margin was 44.5% in FY2023, indicating improvement in operational efficiency.
  • Earnings per Share (EPS): The company reported an EPS of CAD (0.29) in FY2023.

Cash Flow and Balance Sheet Health:

OGI ended FY2023 with a cash balance of CAD 10.8 million. The company's balance sheet shows a total debt-to-equity ratio of 1.2, indicating a moderate level of financial leverage.

Dividends and Shareholder Returns:

Dividend History:

OGI has not paid dividends to date, as the company is focused on reinvesting its earnings for growth.

Shareholder Returns:

OGI's stock price has experienced volatility in recent years. Over the past year, the stock price has increased by 15%. However, over the past five years, the stock price has declined by 60%.

Growth Trajectory:

Historical Growth:

OGI has experienced significant revenue growth over the past five years, driven by increasing demand for cannabis products and the expansion of its production capacity.

Future Growth Projections:

The company expects continued growth in the years ahead, driven by factors such as the launch of new products, expansion into new markets, and increasing consumer awareness of cannabis.

Recent Product Launches and Strategic Initiatives:

  • Launch of Edison Cannabis vapes: OGI expanded its Edison Cannabis brand with the launch of a new line of vape cartridges in 2023.
  • Expansion into the United States: The company is exploring opportunities to enter the US cannabis market through partnerships and acquisitions.
  • Focus on innovation: OGI is investing in research and development to develop innovative cannabis products and technologies.

Market Dynamics:

Current Trends:

The cannabis industry is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. The industry is also seeing a shift towards premium products and value-oriented options.

Demand-Supply Scenarios:

The supply of cannabis is increasing as more producers enter the market. However, demand is also growing, leading to a balanced market.

Technological Advancements:

Technological advancements are playing a key role in the cannabis industry, with companies developing new cultivation techniques, processing methods, and product delivery systems.

Positioning and Adaptability:

OGI is positioned as a leading cannabis producer with a strong brand portfolio and a focus on innovation. The company is well-positioned to adapt to changing market dynamics through its diversified product offerings and strategic initiatives.

Competitors:

Key Competitors:

  • Canopy Growth Corporation (CGC)
  • Tilray Inc. (TLRY)
  • Aurora Cannabis Inc. (ACB)
  • Aphria Inc. (APHA)

Market Share Percentages:

OGI holds a market share of approximately 3% in the Canadian cannabis market. Its main competitors hold larger market shares, with Canopy Growth at 15%, Tilray at 10%, Aurora Cannabis at 8%, and Aphria at 7%.

Competitive Advantages and Disadvantages:

Advantages:

  • Strong brand portfolio
  • Focus on innovation
  • Vertically integrated operations
  • Experienced management team

Disadvantages:

  • Smaller market share compared to major competitors
  • Limited international presence
  • Operating in a competitive and evolving industry

Potential Challenges and Opportunities:

Key Challenges:

  • Intense competition
  • Regulatory uncertainty
  • Supply chain disruptions
  • Consumer preferences and perceptions

Potential Opportunities:

  • Growth of the cannabis market
  • Expansion into new markets
  • Development of innovative products
  • Strategic partnerships

Recent Acquisitions (Last 3 Years):

OGI has not made any significant acquisitions in the past three years. However, the company has entered into strategic partnerships with other companies in the cannabis industry.

AI-Based Fundamental Rating:

Rating: 7/10

Justification:

OGI is a well-positioned cannabis producer with a strong brand portfolio, a focus on innovation, and experienced management. However, the company faces intense competition and operates in a rapidly evolving industry. The AI-based rating of 7/10 reflects the company's potential for growth but also acknowledges the challenges it faces.

Sources and Disclaimers:

Sources:

  • OrganiGram Holdings Inc. Investor Relations
  • S&P Global Market Intelligence
  • Statista
  • Grand View Research

Disclaimer:

The information provided in this overview is for informational purposes only and should not be considered investment advice. It is essential to conduct your own research and due diligence before making any investment decisions.

About OrganiGram Holdings Inc

Exchange NASDAQ
Headquaters Toronto, ON, Canada
IPO Launch date 2014-08-27
CEO & Director Ms. Beena G. Goldenberg
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 1093
Full time employees 1093

Organigram Holdings Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. The company is headquartered in Toronto, Canada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​